Trade Names:
Synonyms:
Status: Approved (2010)
Entry Type: Protein
Molecule Category: Salt
UNII: LGW5H38VE3
Parent Compound: TESAMORELIN

Pharmacology

Action Mechanism of Action Reference
AGONIST Growth hormone-releasing hormone receptor agonist DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference

Related Entries

Parent

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
18.45
Injury, poisoning and procedural complications
11.62
Skin and subcutaneous tissue disorders
11.32
Musculoskeletal and connective tissue disorders
10.06
Nervous system disorders
8.52
Investigations
5.49
Gastrointestinal disorders
5.47
Cardiac disorders
5.34
Vascular disorders
5.3
Respiratory, thoracic and mediastinal disorders
3.35
Infections and infestations
3.07
Psychiatric disorders
2.97
Metabolism and nutrition disorders
2.22

Cross References

Resources Reference
ChEMBL CHEMBL2111290
FDA SRS LGW5H38VE3
PubChem 44147413